Strongid Caramel 43.72% w/w Oral Paste

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Pyrantel Embonate

Available from:

Eli Lilly & Company Ltd

INN (International Name):

Pyrantel Embonate

Authorization status:

Expired

Summary of Product characteristics

Revised: March 2011
AN: 01790/2010
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
STRONGID™ CARAMEL
43.72 % w/w Oral Paste
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE
Pyrantel Embonate 43.72 %w/w
One oral doser contains 26g paste, supplying 11.4g Pyrantel Embonate.
For a full list of excipients see section 6.1
3.
PHARMACEUTICAL FORM
Oral paste.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses, ponies, donkeys and foals over four weeks of age.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
A broad spectrum anthelmintic for use in horses and donkeys for the
control
and treatment of adult infections of large and small strongyles,
_Oxyuris, _
_Parascaris _and _Anoplocephala perfoliata._
Effective against benzimidazole resistant strains of small strongyles.
4.3
CONTRAINDICATIONS
None known.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase
the risk of development of resistance and could ultimately result in
ineffective
therapy:

Too frequent and repeated use of anthelmintics from the same class,
over
an extended period of time.

Underdosing, which may be due to underestimation of body weight,
misadministration of the product, or lack of calibration of the dosing
device (if
any).
Page 1 of 5
Revised: March 2011
AN: 01790/2010
Suspected clinical cases of resistance to anthelmintics should be
further
investigated using appropriate tests (e.g. Faecal Egg Count Reduction
Test).
Where the results of the test(s) strongly suggest resistance to a
particular
anthelmintic, an anthelmintic belonging to another pharmacological
class and
having a different mode of action should be used.
Resistance to pyrantel has been reported in cyathostomes in horses in
a
number of countries including the EU. Therefore, the use of this
product
should be based on local (regional, farm) epidemiological information
about
susceptibility of nematodes and recommendations on how to limit
further
selection for resistance to anthe